| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.18 | 0.5 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |